The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N).
 
Golnaz Morad
No Relationships to Disclose
 
Yitao Yang
No Relationships to Disclose
 
Sheila Duncan
No Relationships to Disclose
 
Sherise D. Ferguson
No Relationships to Disclose
 
Jennifer Ann Wargo
Stock and Other Ownership Interests - Micronoma; OSE Immunotherapeutics
Honoraria - Bristol-Myers Squibb; DAVA Oncology; Gilead Sciences; Illumina; Imedex/HMP; MedImmune; Omniprex; Peerview; Physicans' Education Resource
Consulting or Advisory Role - AstraZeneca; Biothera; Bristol Myers Squibb Foundation; GlaxoSmithKline; Merck; Micronoma; Novartis; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; DAVA Oncology; Gilead Sciences; Illumina; Imedex/HMP; MedImmune; Omniprex; Peerview; Physicans' Education Resource
Patents, Royalties, Other Intellectual Property - US20200129569A1; WO2019191390A2; WO2020106983A1; WO2020150429A1
 
Elizabeth M. Burton
No Relationships to Disclose
 
Hussein A. Tawbi
Consulting or Advisory Role - Boxer Capital; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; Jazz Pharmaceuticals; Karyopharm Therapeutics; Medicenna; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Dragonfly Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); RAPT Therapeutics (Inst)
 
Michael A. Davies
Consulting or Advisory Role - ABM; Apexigen; Array BioPharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; NanoString Technologies; Novartis; Pfizer
Research Funding - ABM (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lead Pharma (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Pfizer (Inst); Sanofi (Inst)
 
Han Liang
Stock and Other Ownership Interests - Precision Scientific
Consulting or Advisory Role - Precision Scientific
 
Isabella Claudia Glitza
Honoraria - Amgen
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Leal Therapeutics; Midatech Pharma; Novartis; Sintetica
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)